Global Biologics CDMO Market

$2,850.00

产品代码: GH03720R 行业: 地区:

The global biologics CDMO market is expected to increase by USD 9.7 十亿, 以复合年增长率 (复合年增长率) 的 10.2% 从 2022 到 2028, according to the latest edition of the Global Biologics CDMO Market Report.

该报告涵盖了市场规模和增长, 分割, 区域细分, 竞争格局, trends and strategies for global biologics CDMO market. 它追踪市场的历史和预测市场增长. 该报告根据市场趋势和主要竞争对手的方法确定了最重要的机会和战略细分市场. This study also provides an analysis of the impact of the COVID-19 crisis on the biologics CDMO industry.

该行业报告提供了全球市场的市场估计和预测, 其次是类型的详细分析, 产品类别, 和地区. The global market for biologics CDMO can be segmented by type: mammalian, non-mammalian. The mammalian segment is estimated to account for the largest share of the global biologics CDMO market. Biologics CDMO market is further segmented by product type: 生物制剂, biosimilars. The biologics segment held the largest revenue share in 2021. 根据地区, the biologics CDMO market is segmented into: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美. 全球范围, North America made up the largest share of the biologics CDMO market.

The biologics market is further segmented into monoclonal, recombinant protein, antisense and molecular therapy, 疫苗. The monoclonal segment held the largest share of the global biologics CDMO market in 2021 预计在预测期内将持有其份额.

市场细分
按类型: mammalian, non-mammalian
按产品类型: 生物制剂, biosimilars
按地区: 北美, 欧洲, 亚太, 事物 (中东和非洲), 拉美

The market research report covers the analysis of key stake holders of the global biologics CDMO market. Some of the leading players profiled in the report include BINEX Co., 有限公司, Boehringer Ingelheim GmbH, Catalent Inc., Fujifilm Diosynth Biotechnologies USA Inc., ICON plc, 龙沙集团公司, Parexel International Corp., Samsung Biologics Co., 有限公司, Samsungbioepis Co., 有限公司, Sandoz Biopharmaceuticals AG, Toyobo Co., 有限公司, WuXi AppTec Inc., Wuxi Biologics Cayman Inc., 除其他外.
*索取免费样品以获得完整的公司列表

历史 & 预测期
本研究报告对各个细分市场进行了分析 2018 到 2028 考虑到 2021 为基准年.

报告范围
To analyze and forecast the market size of the global biologics CDMO market.
To classify and forecast the global biologics CDMO market based on type, 产品类别, 地区.
To identify drivers and challenges for the global biologics CDMO market.
– 检查合并等竞争性发展 & 收购, 协议, 合作与伙伴关系, ETC。, in the global biologics CDMO market.
To identify and analyze the profile of leading players operating in the global biologics CDMO market.

为什么选择这份报告
Gain a reliable outlook of the global biologics CDMO market forecasts from 2022 到 2028 跨场景.
– 确定投资的增长领域.
– 通过公司简介和市场数据领先于竞争对手.
– Excel 格式的跨场景分析易用性的市场预估.
– 三个月的战略咨询和研究支持.
– 为单用户许可证提供打印验证.

Global Biologics CDMO Market

对这份报告感兴趣? 立即获取免费样品!
Global Biologics CDMO Market - 报告范围
报告属性

细节

基准年

2021

预测年份

2022-2028

复合年增长率 (2022-2028)

10.24%

页数

88

行业参与者

BINEX Co. 有限公司, Boehringer Ingelheim GmbH, Catalent Inc., Fujifilm Diosynth Biotechnologies USA Inc., ICON plc, 龙沙集团公司, Parexel International Corp., Samsung Biologics Co. 有限公司, Samsungbioepis Co. 有限公司, Sandoz Biopharmaceuticals AG, Toyobo Co. 有限公司, WuXi AppTec Inc., Wuxi Biologics Cayman Inc.

相关报道
想要定制此报告?
本报告可以灵活地根据您的具体需求进行定制. 我们的分析师和行业专家团队将直接与您合作,全面了解您的需求.
滚动至顶部

下载免费样品 - Global Biologics CDMO Market

请填写我们的表格,我们会尽快回复您.